Combined treatment of an intratumoral injection of dendritic cells and systemic chemotherapy (paclitaxel) for murine fibrosarcoma

Gwang Seong Choi, Moon Hee Lee, Soon Ki Kim, Chul Soo Kim, Hong Sik Lee, Moon Whan Im, Hye Yun Kil, Do Hwan Seong, Jong Rok Lee, Woo Chul Kim, Min Geol Lee, Sun U. Song

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

A novel combined treatment of conventional chemotherapy with an intratumoral injection of syngeneic dendritic cells (DCs) has emerged as a potent cancer treatment strategy. In this study, we evaluated the synergistic effect of an intraperitoneal (i.p.) injection of a chemotherapeutic drug, paclitaxel, and an intratumoral (i.t.) injection of syngeneic bone marrow-derived DCs for the treatment of pre-existing fibrosarcoma. Subcutaneous tumors were established using MCA102 fibrosarcoma cells in syngeneic C57BL/6 mice. The results demonstrated that the combined treatment of paclitaxel chemotherapy and the injection of DCs led to complete tumor regression, in contrast to only partial eradication of the tumors with chemotherapy or DCs alone. Furthermore, the tumo-free mice were able to resist a repeat challenge with tile same type of tumor. These findings suggest that a combination therapy of systemic chemotherapy along with the intratumoral administration of DCs is a potent treatment strategy for fibrosarcoma.

Original languageEnglish
Pages (from-to)835-842
Number of pages8
JournalYonsei medical journal
Volume46
Issue number6
DOIs
Publication statusPublished - 2005 Dec

Fingerprint

Fibrosarcoma
Paclitaxel
Dendritic Cells
Drug Therapy
Injections
Neoplasms
Therapeutics
Intraperitoneal Injections
Inbred C57BL Mouse
Bone Marrow
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Choi, Gwang Seong ; Lee, Moon Hee ; Kim, Soon Ki ; Kim, Chul Soo ; Lee, Hong Sik ; Im, Moon Whan ; Kil, Hye Yun ; Seong, Do Hwan ; Lee, Jong Rok ; Kim, Woo Chul ; Lee, Min Geol ; Song, Sun U. / Combined treatment of an intratumoral injection of dendritic cells and systemic chemotherapy (paclitaxel) for murine fibrosarcoma. In: Yonsei medical journal. 2005 ; Vol. 46, No. 6. pp. 835-842.
@article{94e81448a897455eb7b4613b2a7ba84c,
title = "Combined treatment of an intratumoral injection of dendritic cells and systemic chemotherapy (paclitaxel) for murine fibrosarcoma",
abstract = "A novel combined treatment of conventional chemotherapy with an intratumoral injection of syngeneic dendritic cells (DCs) has emerged as a potent cancer treatment strategy. In this study, we evaluated the synergistic effect of an intraperitoneal (i.p.) injection of a chemotherapeutic drug, paclitaxel, and an intratumoral (i.t.) injection of syngeneic bone marrow-derived DCs for the treatment of pre-existing fibrosarcoma. Subcutaneous tumors were established using MCA102 fibrosarcoma cells in syngeneic C57BL/6 mice. The results demonstrated that the combined treatment of paclitaxel chemotherapy and the injection of DCs led to complete tumor regression, in contrast to only partial eradication of the tumors with chemotherapy or DCs alone. Furthermore, the tumo-free mice were able to resist a repeat challenge with tile same type of tumor. These findings suggest that a combination therapy of systemic chemotherapy along with the intratumoral administration of DCs is a potent treatment strategy for fibrosarcoma.",
author = "Choi, {Gwang Seong} and Lee, {Moon Hee} and Kim, {Soon Ki} and Kim, {Chul Soo} and Lee, {Hong Sik} and Im, {Moon Whan} and Kil, {Hye Yun} and Seong, {Do Hwan} and Lee, {Jong Rok} and Kim, {Woo Chul} and Lee, {Min Geol} and Song, {Sun U.}",
year = "2005",
month = "12",
doi = "10.3349/ymj.2005.46.6.835",
language = "English",
volume = "46",
pages = "835--842",
journal = "Yonsei Medical Journal",
issn = "0513-5796",
publisher = "Yonsei University College of Medicine",
number = "6",

}

Choi, GS, Lee, MH, Kim, SK, Kim, CS, Lee, HS, Im, MW, Kil, HY, Seong, DH, Lee, JR, Kim, WC, Lee, MG & Song, SU 2005, 'Combined treatment of an intratumoral injection of dendritic cells and systemic chemotherapy (paclitaxel) for murine fibrosarcoma', Yonsei medical journal, vol. 46, no. 6, pp. 835-842. https://doi.org/10.3349/ymj.2005.46.6.835

Combined treatment of an intratumoral injection of dendritic cells and systemic chemotherapy (paclitaxel) for murine fibrosarcoma. / Choi, Gwang Seong; Lee, Moon Hee; Kim, Soon Ki; Kim, Chul Soo; Lee, Hong Sik; Im, Moon Whan; Kil, Hye Yun; Seong, Do Hwan; Lee, Jong Rok; Kim, Woo Chul; Lee, Min Geol; Song, Sun U.

In: Yonsei medical journal, Vol. 46, No. 6, 12.2005, p. 835-842.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Combined treatment of an intratumoral injection of dendritic cells and systemic chemotherapy (paclitaxel) for murine fibrosarcoma

AU - Choi, Gwang Seong

AU - Lee, Moon Hee

AU - Kim, Soon Ki

AU - Kim, Chul Soo

AU - Lee, Hong Sik

AU - Im, Moon Whan

AU - Kil, Hye Yun

AU - Seong, Do Hwan

AU - Lee, Jong Rok

AU - Kim, Woo Chul

AU - Lee, Min Geol

AU - Song, Sun U.

PY - 2005/12

Y1 - 2005/12

N2 - A novel combined treatment of conventional chemotherapy with an intratumoral injection of syngeneic dendritic cells (DCs) has emerged as a potent cancer treatment strategy. In this study, we evaluated the synergistic effect of an intraperitoneal (i.p.) injection of a chemotherapeutic drug, paclitaxel, and an intratumoral (i.t.) injection of syngeneic bone marrow-derived DCs for the treatment of pre-existing fibrosarcoma. Subcutaneous tumors were established using MCA102 fibrosarcoma cells in syngeneic C57BL/6 mice. The results demonstrated that the combined treatment of paclitaxel chemotherapy and the injection of DCs led to complete tumor regression, in contrast to only partial eradication of the tumors with chemotherapy or DCs alone. Furthermore, the tumo-free mice were able to resist a repeat challenge with tile same type of tumor. These findings suggest that a combination therapy of systemic chemotherapy along with the intratumoral administration of DCs is a potent treatment strategy for fibrosarcoma.

AB - A novel combined treatment of conventional chemotherapy with an intratumoral injection of syngeneic dendritic cells (DCs) has emerged as a potent cancer treatment strategy. In this study, we evaluated the synergistic effect of an intraperitoneal (i.p.) injection of a chemotherapeutic drug, paclitaxel, and an intratumoral (i.t.) injection of syngeneic bone marrow-derived DCs for the treatment of pre-existing fibrosarcoma. Subcutaneous tumors were established using MCA102 fibrosarcoma cells in syngeneic C57BL/6 mice. The results demonstrated that the combined treatment of paclitaxel chemotherapy and the injection of DCs led to complete tumor regression, in contrast to only partial eradication of the tumors with chemotherapy or DCs alone. Furthermore, the tumo-free mice were able to resist a repeat challenge with tile same type of tumor. These findings suggest that a combination therapy of systemic chemotherapy along with the intratumoral administration of DCs is a potent treatment strategy for fibrosarcoma.

UR - http://www.scopus.com/inward/record.url?scp=30644477467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30644477467&partnerID=8YFLogxK

U2 - 10.3349/ymj.2005.46.6.835

DO - 10.3349/ymj.2005.46.6.835

M3 - Article

C2 - 16385661

AN - SCOPUS:30644477467

VL - 46

SP - 835

EP - 842

JO - Yonsei Medical Journal

JF - Yonsei Medical Journal

SN - 0513-5796

IS - 6

ER -